The WINA (Whole Inactivated bacteria bearing Native Antigens) platform allows to inactivate bacteria without destroying or modifying the antigens and the conformation, allowing a very high efficacy as a vaccine.
About BCV Care
BCV Care is a startup incorporated in France that develops the WINA platform to bring solutions against the evergroing problem of antimicrobial resistance (AMR) with new and efficient vaccines.
The team Dr. Colette Kanellopoulos-Langevin CEO PhD, Co-inventor, Co-founder Emeritus Research Director CNRS, Immunobiology, UMR Inserm 1149
Dr. Philippe Verbeke CSO PhD, Co-inventor, Partner Associate Professor, Univ, Paris Cité, Host-Pathogens interaction, UMR Inserm 1149
Loïc Tron, Business Associate 20+ years founding deeptech startups in chemistry, cleantech and biotechnologies
BCV Care is a startup incorporated in France that develops the WINA platform to bring solutions against the evergroing problem of antimicrobial resistance (AMR) with new and efficient vaccines.
